Mohsen Alzahrani

837 total citations
58 papers, 214 citations indexed

About

Mohsen Alzahrani is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Mohsen Alzahrani has authored 58 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 25 papers in Genetics and 14 papers in Oncology. Recurrent topics in Mohsen Alzahrani's work include Hemoglobinopathies and Related Disorders (15 papers), Lymphoma Diagnosis and Treatment (11 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Mohsen Alzahrani is often cited by papers focused on Hemoglobinopathies and Related Disorders (15 papers), Lymphoma Diagnosis and Treatment (11 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Mohsen Alzahrani collaborates with scholars based in Saudi Arabia, United States and Lebanon. Mohsen Alzahrani's co-authors include Moussab Damlaj, Bader Alahmari, Ahmed Alaskar, Khadega A. Abuelgasim, Giamal Gmati, Neal Jeffries, Damiano Rondelli, John F. Tisdale, Santosh L. Saraf and Matthew M. Hsieh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Mohsen Alzahrani

46 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohsen Alzahrani Saudi Arabia 8 76 74 41 39 39 58 214
Sunita Nathan United States 9 79 1.0× 57 0.8× 16 0.4× 19 0.5× 11 0.3× 34 198
Mariarita Sciumé Italy 9 94 1.2× 64 0.9× 39 1.0× 27 0.7× 10 0.3× 26 214
Francisco J. Márquez‐Malaver Spain 9 171 2.3× 39 0.5× 47 1.1× 25 0.6× 39 1.0× 21 266
Dawn Sheppard Canada 8 124 1.6× 26 0.4× 16 0.4× 33 0.8× 37 0.9× 17 284
Nosha Farhadfar United States 11 188 2.5× 52 0.7× 67 1.6× 13 0.3× 24 0.6× 49 318
Nicola Orofino Italy 10 173 2.3× 151 2.0× 64 1.6× 22 0.6× 10 0.3× 22 266
Şule Mine Bakanay Türkiye 9 163 2.1× 141 1.9× 33 0.8× 8 0.2× 21 0.5× 36 261
Katalin Csordás Hungary 11 76 1.0× 31 0.4× 53 1.3× 12 0.3× 34 0.9× 21 329
Cristina Beléndez Spain 10 198 2.6× 193 2.6× 31 0.8× 21 0.5× 13 0.3× 41 302
Jasmita Dass India 9 100 1.3× 71 1.0× 39 1.0× 46 1.2× 4 0.1× 59 251

Countries citing papers authored by Mohsen Alzahrani

Since Specialization
Citations

This map shows the geographic impact of Mohsen Alzahrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohsen Alzahrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohsen Alzahrani more than expected).

Fields of papers citing papers by Mohsen Alzahrani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohsen Alzahrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohsen Alzahrani. The network helps show where Mohsen Alzahrani may publish in the future.

Co-authorship network of co-authors of Mohsen Alzahrani

This figure shows the co-authorship network connecting the top 25 collaborators of Mohsen Alzahrani. A scholar is included among the top collaborators of Mohsen Alzahrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohsen Alzahrani. Mohsen Alzahrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wijesinghe, Dayanjan S., et al.. (2025). Unraveling the Complex Genomic Interplay of Sickle Cell Disease Among the Saudi Population: A Case-Control GWAS Analysis. International Journal of Molecular Sciences. 26(6). 2817–2817. 1 indexed citations
2.
Aboshaiqah, Ahmad E., et al.. (2025). The Lived Experience of Adult Cancer Survivors After Hematopoietic Stem Cell Transplantation: A Qualitative Study From Saudi Arabia. Patient Preference and Adherence. Volume 19. 279–293.
3.
4.
5.
6.
Alzahrani, Mohsen, et al.. (2024). Outcome of Respiratory Viral Infections in Hematopoietic Stem Cell Transplant Recipients. Transplantation Proceedings. 56(1). 186–190.
7.
Alzahrani, Mohsen, et al.. (2024). Challenges of Treating a Patient with Autism and Hodgkin’s Lymphoma. SHILAP Revista de lepidopterología. 15(3). 250–253.
8.
Alzahrani, Mohsen, et al.. (2023). Improving Utilization of the Chemotherapy Unit through Implementing the Medication Early Release Project. SHILAP Revista de lepidopterología. 6(3). 81–88. 2 indexed citations
9.
10.
Alzahrani, Mohsen, et al.. (2023). Impact of Genetic Variations on Thromboembolic Risk in Saudis with Sickle Cell Disease. Genes. 14(10). 1919–1919. 3 indexed citations
11.
Alghamdi, Ali, et al.. (2023). Improved Quality of Life of Patients With Sickle Cell Disease after Allogeneic Stem Cell Transplant: Another Indication for Transplant. Hematology/Oncology and Stem Cell Therapy. 17(1). 37–42. 2 indexed citations
12.
13.
Khalid, Farhan, Moussab Damlaj, Mohsen Alzahrani, Khadega A. Abuelgasim, & Giamal Gmati. (2020). Reactivation of tuberculosis following ruxolitinib therapy for primary myelofibrosis. Hematology/Oncology and Stem Cell Therapy. 14(3). 252–256. 12 indexed citations
14.
Damlaj, Moussab, Farhan Khalid, Bader Alahmari, et al.. (2020). Optimal pre-emptive cytomegalovirus therapy threshold in a patient population with high prevalence of seropositive status. Current Research in Translational Medicine. 68(3). 131–137. 5 indexed citations
15.
Baharoon, Salim, et al.. (2019). Advance directive preferences of patients with chronic and terminal illness towards end of life decisions: a sample from Saudi Arabia. Eastern Mediterranean Health Journal. 25(11). 791–797. 5 indexed citations
16.
Damlaj, Moussab, et al.. (2018). Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma. World Journal of Transplantation. 8(7). 252–261. 3 indexed citations
17.
18.
Alzahrani, Mohsen, Ahmed Alaskar, Moussab Damlaj, et al.. (2017). Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia. Blood. 130. 5549–5549. 1 indexed citations
19.
Balwi, Mohammed Al, Mohammed Al Balwi, Talal Al‐Harbi, et al.. (2016). Clinical characteristics and genetic subtypes of Fanconi anemia in Saudi patients. Cancer Genetics. 209(4). 171–176. 11 indexed citations
20.
Fakhoury, Hana, Mohsen Alzahrani, Ahmed Alaskar, & Ali H. Hajeer. (2015). Description of a novel HLA‐DQB1 allele, HLA‐DQB1*06:126, in the Saudi stem cell donor registry. HLA. 87(1). 58–59. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunita Nathan Breakdown of academic impact, for papers by Mariarita Sciumé Breakdown of academic impact, for papers by Francisco J. Márquez‐Malaver Breakdown of academic impact, for papers by Dawn Sheppard Breakdown of academic impact, for papers by Nosha Farhadfar Breakdown of academic impact, for papers by Nicola Orofino Breakdown of academic impact, for papers by Şule Mine Bakanay Breakdown of academic impact, for papers by Katalin Csordás Breakdown of academic impact, for papers by Cristina Beléndez Breakdown of academic impact, for papers by Jasmita Dass
Rankless by CCL
2026